News

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.

Selected early versions will be slated for real-world deployment. 

The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.

Patients will get same-day delivery and access to treatments like GLP-1s and hormone therapies.   

Julien Payen, cofounder and CEO of Lattice Medical, describes the company's 3D-printed, resorbable breast implant that uses a patient's own fat to regenerate natural breast tissue after a mastectomy.

Amazon Diagnostics provides home sample collection in under 60 minutes and lab results in less than six hours.  

The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.

The company's virtual reality and augmented reality apps pair with external neurofeedback or biofeedback wearable devices.